Roche is among several drugmakers to announce large-scale U.S. investments in response to Trump's push to onshore ...

Roche warned that President Trump's executive order on drug pricing threatens its planned $50 billion investment in the ...

President Donald Trump's plans to dramatically slash drug prices for Americans could make Swiss pharmaceutical giant Roche cancel major investments in ...

US President Trump has taken aim at Europe for undercharging for medicine. But raising prices in Europe would face strong ...

France's Sanofi is the latest European pharma group to promise a big capital investment programme on manufacturing and R&D in ...

It’s not immediately clear what the scope of these operations will be — beyond manufacturing at both Sanofi and “partners ...

By November 2033, Utah’s next Winter Games will kick off with the Olympic Torch Relay that brings a flame lit in ancient ...

An executive order signed by U.S. President Donald Trump on drug pricing could jeopardize Roche's substantial $50 billion investment in the United States. The order requires drug manufacturers to ...

The recent executive order signed by U.S. President Donald Trump poses a threat to Roche's $50 billion investment plan in the United States, the pharmaceutical giant stated on Wednesday. The directive ...

U.S. private equity group Carlyle Group is expected to clinch in the coming days an accord to sell Italian fashion brand ...